Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1996-07-29
1998-07-28
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424484, 424489, 424 7808, 514 2, 514261, 514944, 514963, 514579, A61K 9127, A61K 916, A61K 952
Patent
active
057859930
ABSTRACT:
SOD and other active oxygen inhibitors are directly applied in combination with a barrier material at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells. Preferred barrier materials are polymeric hydrogels providing controlled release of AOI which are directly applied to the afflicted tissue. Examples demonstrate the effects of SOD on pelvic adhesions in the rat when administered by intraperitoneal (I.P.) bolus and by localized sustained release from a topically applied hydrogel system.
REFERENCES:
patent: 3784585 (1974-01-01), Schmitt et al.
patent: 4371519 (1983-02-01), Hettinger, Jr.
patent: 4511478 (1985-04-01), Nowinski et al.
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4563349 (1986-01-01), Miyata et al.
patent: 4603695 (1986-08-01), Ikada et al.
patent: 4741872 (1988-05-01), De Luca et al.
patent: 4745161 (1988-05-01), Saudek et al.
patent: 4760051 (1988-07-01), Pickart
patent: 4804691 (1989-02-01), English et al.
patent: 4806621 (1989-02-01), Kohn et al.
patent: 4826945 (1989-05-01), Cohn et al.
patent: 4873292 (1989-10-01), Ogata et al.
patent: 4888413 (1989-12-01), Domb
patent: 4889722 (1989-12-01), Sheffield et al.
patent: 4897308 (1990-01-01), Vanlerberghe
patent: 4898734 (1990-02-01), Mathiowitz et al.
patent: 4911926 (1990-03-01), Henry et al.
patent: 4925677 (1990-05-01), Feijen
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4938763 (1990-07-01), Dunn et al.
patent: 4942035 (1990-07-01), Churchill et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 4976959 (1990-12-01), Berger, Jr. et al.
patent: 4994277 (1991-02-01), Higham et al.
patent: 5066590 (1991-11-01), Yabuki et al.
patent: 5100992 (1992-03-01), Cohn et al.
patent: 5108755 (1992-04-01), Daniels et al.
patent: 5126141 (1992-06-01), Henry
patent: 5135751 (1992-08-01), Henry et al.
patent: 5137820 (1992-08-01), Maeda et al
patent: 5143731 (1992-09-01), Viegas et al.
patent: 5160745 (1992-11-01), De Luca et al.
patent: 5175235 (1992-12-01), Domb et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5217966 (1993-06-01), Bruice
patent: 5219564 (1993-06-01), Zalipsky et al.
patent: 5223538 (1993-06-01), Fridovich et al.
patent: 5227405 (1993-07-01), Fridovich et al.
patent: 5260204 (1993-11-01), Heckl et al.
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5286763 (1994-02-01), Gerhart et al.
patent: 5288502 (1994-02-01), McGinity
patent: 5292516 (1994-03-01), Viegas et al.
patent: 5328471 (1994-07-01), Slepian
patent: 5364622 (1994-11-01), Franz et al.
patent: 5366735 (1994-11-01), Henry
patent: 5384333 (1995-01-01), Davis et al.
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5419917 (1995-05-01), Chen
patent: 5512092 (1996-04-01), Maruyama et al.
patent: 5519035 (1996-05-01), Maiese et al.
patent: 5527864 (1996-06-01), Suggs et al.
patent: 5561158 (1996-10-01), Yu et al.
patent: 5562594 (1996-10-01), Weeks
patent: 5589169 (1996-12-01), Mohler et al.
Technical bulletin, UNIMED, 1992.
Hom et al., "Vascular effects of sustained-release fibroblast growth factors," Ann. Otol. Rhinol. Laryngol., 105:109-116 (1996).
Diamond et al., "Adhesion reformation and de novo adhesion formation after reproductive pelvic surgery," Fert. and Ster. 47:864 (1987).
Dumanian, et al., "A New Photopolymerizable Blood Vessel Glue That Seals Human Vessel Anastomoses Without Augmenting Thrombogenicity," Plastic and Reconstructive Surgery 95(5):901-907 (1995).
Dunn, et al., "Synergistic effect of intraperitoneally administered calcium channel blockade and recombinant tissue," Am. J. Obstet. Gynecol. 164:1327-1330 (1991).
Fridovich, "Biological Effects of the Superoxide Radical," Arch. Bioch. & Biophys. 247:1-11 (1986).
Haney, A.F., "Murine peritoneal injury and de novo adhesion formation expanded polytetrafluoroethylene (Gore-Tex* Surgical Membrane)," Fertility and Sterility 57:202-208 (1992).
Hill-West, et al., "Prevention of Postoperative Adhesions in the Rat by In Situ Photopolymerization of Bioresorbable Hydrogel Barriers," Obstet. Gynecol. 83:59-64 (1994).
Kontos, et al., "Oxygen Radicals in Brain Injury," CNS Trauma 3:257-263 (1986).
Luciano, et al., "A Comparative Study of Postoperative Adhesions Following Laser Surgery by Laparoscopy Versus Laparotomy in the Rabbit Model," Obstet. & Gyn. 74:220 (1989).
Luciano, et al., "A comparison of thermal injury, healing patters, and postoperative adhesion formation following CO.sub.2 laser and electromicrosurgery," Fert. and Ster. 48:1025 (1987).
Monk, et al., "Adhesions after extensive gynecologic surgery: Clinical significance, etiology, and prevention," Am. J. Obstet. Gynecol. 170:1396-1403 (1994).
Odlind, et al., "Tissue Distribution of .sup.125 I-Labelled Bovine Superoxide Dismutase (SOD) in the Rat," Pharmacol. Toxic 62:95-100 (1988).
Peters, et al., "A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain," Br. J. Obstet. Gyn. 99:59 (1992).
Petkau, et al., "Tissue Distribution of Bovine .sup.125 I-Superoxide Dismutase in Mice," Res. Commun. Chem. Pathol. Pharmacol. 15:641-654 (1976).
Pijlman, et al., "Prevention of adhesions," Eur. J. Ost & Gyn. Repro. Biol. 53:155-163 (1994).
Portz et al., "Oxygen Free Radicals and Pelvic Adhesion Formation: I. Blocking Oxygen Free Radical Toxicity to Prevent Adhesion Formation in an Endometriosis Model," Int. J. Fertil. 36:39-42 (1991).
Pyatak, et al., "Preparation of a Polyethylene Glycol: Superoxide Dismutase Adduct, and as Examination of its Blood Circulating Life and Anti-Inflammatory Activity," Res. Comm. Chem. Path. Pharm. 29:113-127 (1980).
Rodgers, et al., "Partial Splenectomy for Gaucher's Disease," Ann. Surg. Jun.:693-698 (1987).
Sawhney, et al., "Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility," Biomaterials 14:1008-1016 (1993).
Sawhney, et al., "Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention," J. Biomed. Mets. Res. 28, 831-838 (1994).
Schneider, et al., "Comparison of the Protective Effects by Human and Bovine Superoxide Dismutase Against Ischemia-and Reperfusion-Induced Impairment of Kidney Function in Anesthetized Rats," Fr. Rad. Biol. & Med. 3:21-26 (1987).
Schwartz, et al., "Formation, Reduction, and Treatment of Adhesive Disease," Sem. in Repro. Endocrin. 9:89-99 (1991).
Steinleitner, Alex, et al., "An evaluation of Flowgel* as an intraperitonael barrier for prevention of postsurgical adhesion reformation," Fertility and Sterility 57:305-308 (1992).
Surrey, et al., "Second-Look Laparoscopy after Reconstructive Pelvic Surgery for Infertility," J. Repro. Med. 27:658 (1982).
Tsimoyiannis, et al., "The Role of Oxygen-Derived Free Radicals In Peritoneal Adhesion Formation Induced by Ileal Ischaemia/Reperfusion," Acta Chir. Scand. 155:171-174 (1989).
Tulandi, Effects of Ringer's Lactate on Postsurgical Adhesion, In: Diamond, et al., eds, vol. 381, Progress in Clinical and Biological Research (NY, Wiley-Liss 1993) 149-153.
Voogd, et al., "Contradictory Effects of Superoxide Dismutase After Global or Regional Ischemia in the Isolated Rat Heart," Fr. Rad. Biol. & Med. 11:71-75 (1991).
Zimmerman, et al., "Mechanisms of Reperfusion Injury," Am. J. Med. Sci. 307:284-292 (1994).
"Arthritis Drug in UK Trials," Chemical Marketing Reporter p. 19 (Mar. 19, 1990).
"PEG-superoxide dismutase reported to be of benefit in head injury," The Pharmaceutical Journal (Jul. 31, 1993).
Baker Keith
Coury Arthur J.
Focal, Inc.
Kishore Gollamudi S.
LandOfFree
Reduction of adhesions using controlled delivery of active oxyge does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduction of adhesions using controlled delivery of active oxyge, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of adhesions using controlled delivery of active oxyge will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-21167